Old Web
English
Sign In
Acemap
>
authorDetail
>
Lars Damstrup
Lars Damstrup
Merck Serono
Pathology
Medicine
Oncology
MEK inhibitor
Internal medicine
2
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours
2018
British Journal of Cancer
Alison M. Schram
Leena Gandhi
Monica M. Mita
Lars Damstrup
Frank Campana
Manuel Hidalgo
Enrique Grande
David M. Hyman
Rebecca S. Heist
Show All
Source
Cite
Save
Citations (34)
Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.
2015
Journal of Clinical Oncology
Eric Van Cutsem
Manuel Hidalgo
Igor Bazin
Jean-Luc Canon
Elena Poddubskaya
Nebojsa Manojlovic
Michele Milella
Dejan Radenkovic
Chris Verslype
Wei Guo
Lars Damstrup
Pascal Hammel
Show All
Source
Cite
Save
Citations (19)
1